StockClub

NYMXF

NYMXFNymox Pharmaceutical Corporation$ --
Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

NYMXF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2024FY2024 Q4
Revenue
0M USD
YoY -
Operating Income
-1M USD
YoY +83.8%
Net Income
-1M USD
YoY +83.9%
EPS
-0.01$
YoY +84.0%

Revenue

$0
FY2022 Q3$0
$0
Q3
FY2022 Q4$0
$0
Q4
FY2023 Q1$0
$0
Q1
FY2023 Q2$0
$0
Q2
FY2023 Q3$0
$0
Q3
FY2023 Q4$0
$0
Q4
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
Actual
$0 (-)

Net Income

$-1.6M
FY2022 Q3$-5.2M
$-5.2M
Q3
FY2022 Q4$-6.6M
$-6.6M
Q4
FY2023 Q1$-1.4M
$-1.4M
Q1
FY2023 Q2$-2.5M
$-2.5M
Q2
FY2023 Q3$-3.5M
$-3.5M
Q3
FY2023 Q4$-8.8M
$-8.8M
Q4
FY2024 Q3$-716,000
$-716,000
Q3
FY2024 Q4$-1.6M
$-1.6M
Q4
Actual
+$7.3M (+82.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$116,000
FY2019
$116,000
FY2020
Actual:$5,000
FY2020
$5,000
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024
Actual:$0
FY2024
$0

Analyst Estimates

No forecast data